Paragon Advisors LLC Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Paragon Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,728 shares of the healthcare conglomerate’s stock after selling 77 shares during the quarter. UnitedHealth Group makes up approximately 1.3% of Paragon Advisors LLC’s investment portfolio, making the stock its 24th largest position. Paragon Advisors LLC’s holdings in UnitedHealth Group were worth $3,934,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC raised its holdings in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. Global Wealth Strategies & Associates lifted its holdings in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC increased its holdings in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on UNH. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Down 0.2 %

Shares of UnitedHealth Group stock opened at $592.23 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $545.02 billion, a P/E ratio of 38.58, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58. The firm has a 50-day simple moving average of $582.84 and a two-hundred day simple moving average of $549.06. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $6.56 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.